Novofem (Estradiol | Norethisterone Acetate, Estradiol)

Estradiol and Norethisterone acetate, the active ingredients in Novofem, are hormones presented as an oral tablet for systemic use. They belong to the combined estrogen‑progestogen hormone therapy class and are indicated for estrogen‑deficiency conditions in adult women. GNH USA supplies Novofem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novofem, a combined estrogen‑progestogen preparation, is employed in hormone replacement therapy to address estrogen deficiency and related conditions.

- Menopausal vasomotor symptoms: alleviates hot flashes and night sweats. - Prevention of post‑menopausal osteoporosis: helps maintain bone mineral density. - Hypoestrogenic states due to ovarian failure: restores hormonal balance.

Novofem may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of breast tissue. - Headache: transient cranial pain. - Bloating: abdominal distension. - Mood changes: irritability or emotional fluctuations. - Breakthrough bleeding: irregular spotting between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Stroke: cerebrovascular accident with neurological deficits. - Myocardial infarction: heart attack due to reduced coronary flow. - Hepatic adenoma: benign liver tumor. - Gallbladder disease: formation of gallstones or inflammation. - Severe allergic reaction: anaphylaxis with rash, swelling, or breathing difficulty.

When prescribing Novofem, clinicians should consider several safety measures.

- Assess cardiovascular risk: evaluate history of thromboembolic events before initiation. - Screen for hormone‑dependent cancers: avoid use in active breast or endometrial cancer. - Monitor liver function: adjust therapy in patients with hepatic impairment. - Consider bone health: incorporate as part of osteoporosis management plans. - Advise against smoking: smoking increases risk of venous thrombosis. - Store at ambient temperature: keep in the original pack, protect from moisture.

Novofem can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Combined oral anticoagulants: may increase bleeding risk. - Selective serotonin reuptake inhibitors: potential additive bleeding tendency. - Hepatic enzyme inducers (e.g., rifampicin): may lower hormone levels, reducing effectiveness.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., carbamazepine): may decrease hormone concentrations. - Antifungal azoles (e.g., ketoconazole): may raise hormone levels, increasing side‑effect risk. - Thyroid hormones: may require dose adjustment of levothyroxine.